All Stories

  1. Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
  2. Comparison of costs of treatment of Degludec/Liraglutide association versus basal bolus therapy
  3. The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis
  4. Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
  5. Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy
  6. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
  7. Economic and outcomes consequences of TachoSil®: a systematic review
  8. Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
  9. Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines
  10. A cost-of-illness study of spina bifida in Italy
  11. Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
  12. Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
  13. Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
  14. Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
  15. Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy